Integrin α2β1 Represents a Prognostic and Predictive Biomarker in Primary Ovarian Cancer
出版年份 2021 全文链接
标题
Integrin α2β1 Represents a Prognostic and Predictive Biomarker in Primary Ovarian Cancer
作者
关键词
-
出版物
Biomedicines
Volume 9, Issue 3, Pages 289
出版商
MDPI AG
发表日期
2021-03-13
DOI
10.3390/biomedicines9030289
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study
- (2021) Francesco Plotti et al. Biomedicines
- β1-Integrin binding to collagen type 1 transmits breast cancer cells into chemoresistance by activating ABC efflux transporters
- (2020) Fabian Baltes et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model
- (2020) Enes Taylan et al. GYNECOLOGIC ONCOLOGY
- Integrated Analysis of Prognostic and Immune Associated Integrin Family in Ovarian Cancer
- (2020) Anqi Wu et al. Frontiers in Genetics
- ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†
- (2019) N Colombo et al. ANNALS OF ONCOLOGY
- Immunotherapy in Ovarian Cancer
- (2019) Weimin Wang et al. Surgical Oncology Clinics of North America
- Are Integrins Still Practicable Targets for Anti-Cancer Therapy?
- (2019) Alday-Parejo et al. Cancers
- Immunotherapy in Ovarian Cancer: Are We There Yet?
- (2019) Lana E. Kandalaft et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
- (2019) Deborah K. Armstrong et al. Journal of the National Comprehensive Cancer Network
- Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment
- (2019) Brown et al. Cancers
- Immune Heterogeneity Between Primary Tumors and Corresponding Metastatic Lesions and Response to Platinum Therapy in Primary Ovarian Cancer
- (2019) Katharina Dötzer et al. Cancers
- Reversing microtubule‐directed chemotherapeutic drug resistance by co‐delivering α2β1 inhibitor and paclitaxel with nanoparticles in ovarian cancer
- (2019) Weihong Zheng et al. CELL BIOLOGY INTERNATIONAL
- Dual targeting of IGF-1R and ErbB3 as a potential therapeutic regimen for ovarian cancer
- (2019) Adam J. Camblin et al. Scientific Reports
- Productive Cross-Talk with the Microenvironment: A Critical Step in Ovarian Cancer Metastasis
- (2019) Aziz et al. Cancers
- The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer Cells
- (2019) Kathleen Wantoch von Rekowski et al. Biomolecules
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of increased integrin-beta 1 expression in solid cancers: a meta-analysis
- (2018) Quanwu Sun et al. OncoTargets and Therapy
- Role of tumor microenvironment in ovarian cancer pathobiology
- (2018) Alia Ghoneum et al. Oncotarget
- The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer
- (2017) Jun Li et al. Oncotarget
- Integrins as Therapeutic Targets: Successes and Cancers
- (2017) Sabine Raab-Westphal et al. Cancers
- Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review
- (2017) et al. Cancers
- 5th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recurrent Disease
- (2016) M. K. Wilson et al. ANNALS OF ONCOLOGY
- A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors
- (2016) B. Milojkovic Kerklaan et al. INVESTIGATIONAL NEW DRUGS
- Predictive biomarkers for checkpoint inhibitor-based immunotherapy
- (2016) Geoffrey T Gibney et al. LANCET ONCOLOGY
- Alpha2beta1 integrin in cancer development and chemoresistance
- (2015) Dalila Naci et al. SEMINARS IN CANCER BIOLOGY
- Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin
- (2014) Jennifer M. Scalici et al. GYNECOLOGIC ONCOLOGY
- Comparative Meta-analysis of Prognostic Gene Signatures for Late-Stage Ovarian Cancer
- (2014) Levi Waldron et al. JNCI-Journal of the National Cancer Institute
- Prognostic Significance of α5β1-integrin Expression in Cervical Cancer
- (2013) Hua-Yi Wang et al. Asian Pacific Journal of Cancer Prevention
- Increased expression of α5β1-integrin is a prognostic marker for patients with gastric cancer
- (2013) J. Ren et al. Clinical & Translational Oncology
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
- (2013) Weiva Sieh et al. LANCET ONCOLOGY
- Cadherin-17 interacts with α2β1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis
- (2013) R A Bartolomé et al. ONCOGENE
- Integrins and metastasis
- (2013) Kirat Kumar Ganguly et al. Cell Adhesion & Migration
- Integrin Targeted Therapeutics
- (2012) Melissa Millard et al. Theranostics
- Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
- (2011) Michael C. Schmid et al. CANCER CELL
- Phase I Study of E7820, an Oral Inhibitor of Integrin -2 Expression with Antiangiogenic Properties, in Patients with Advanced Malignancies
- (2011) M. Mita et al. CLINICAL CANCER RESEARCH
- Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis
- (2011) J V Burnier et al. ONCOGENE
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
- (2010) Josef Rüschoff et al. VIRCHOWS ARCHIV
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via 5-Integrin, which Is a Therapeutic Target
- (2008) K. Sawada et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More